2021
DOI: 10.1007/s11033-020-06125-8
|View full text |Cite
|
Sign up to set email alerts
|

An improved method for precise genome editing in zebrafish using CRISPR-Cas9 technique

Abstract: Current methods of CRISPR-Cas9-mediated site-specific mutagenesis create deletions and small insertions at the target site which are repaired by imprecise non-homologous end-joining. Targeting of the Cas9 nuclease relies on a short guide RNA (gRNA) corresponding to the genome sequence approximately at the intended site of intervention. We here propose an improved version of CRISPR-Cas9 genome editing that relies on two complementary guide RNAs instead of one. Two guide RNAs delimit the intervention site and al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…In fact, the efficiency of precise genome editing can potentially be further enhanced by combining single-stranded DNA (ssDNA) with other approaches that augment precise genome editing, such as the incorporation of small molecules [12,[39][40][41]. It was reported that the repair of Cas9/sgRNA-induced DSBs via HDR was markedly increased by a combination of small molecules and single-stranded oligodeoxynucleotides (ssODNs) [42].…”
Section: Discussionmentioning
confidence: 99%
“…In fact, the efficiency of precise genome editing can potentially be further enhanced by combining single-stranded DNA (ssDNA) with other approaches that augment precise genome editing, such as the incorporation of small molecules [12,[39][40][41]. It was reported that the repair of Cas9/sgRNA-induced DSBs via HDR was markedly increased by a combination of small molecules and single-stranded oligodeoxynucleotides (ssODNs) [42].…”
Section: Discussionmentioning
confidence: 99%
“…Transplantation of healthy NSCs to RTT patients could differentiate to generate neurons and glial cells, which could provide therapeutic benefits in RTT patients. In the in vivo study, the designed CRISPR‐Cas9 system could be texted in the zebrafish model 114–116 . Upon successful preclinical validation, therapeutic and toxicity should be evaluated in clinical trials, which, hopefully, could be translated to patients based on the consistent and positive outcomes of clinical trials.…”
Section: Disease Modelsmentioning
confidence: 99%
“…In the in vivo study, the designed CRISPR-Cas9 system could be texted in the zebrafish model. [114][115][116] Upon successful preclinical validation, therapeutic and toxicity should be evaluated in clinical trials, which, hopefully, could be translated to patients based on the consistent and positive outcomes of clinical trials.…”
Section: Gene and Stem Cell Therapymentioning
confidence: 99%
“…The transgenic line, Tg(Brn3c:GAP43-GFP) s356t (Xiao et al, 2005), which expresses cytosolic EGFP in inner ear and lateral line mechanosensory hair cells, was used in this study. The generation of two kcng4b mutations, C1 and C2, by CRISPR-Cas9 has been described previously (Gasanov et al, 2021).…”
Section: Animalsmentioning
confidence: 99%
“…1A, B). The C-terminal of Kcng4b polypeptide was prematurely terminated with the loss of 29 C-terminal amino-acid residues (Gasanov et al, 2021) (Fig. 1B).…”
Section: Computational Analysis Of Kcng4b Mutantsmentioning
confidence: 99%